Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 1367  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4522    
    Printed127    
    Emailed2    
    PDF Downloaded147    
    Comments [Add]    
    Cited by others 3    

Recommend this journal

 

 CASE REPORT
Year : 2003  |  Volume : 51  |  Issue : 1  |  Page : 98--99

Subependymomas in children: A report of five cases including two with osseous metaplasia


1 Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh-160012, India
2 Department of Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh-160012, India

Correspondence Address:
R K Vasishta
Department of Histopathology, PGIMER, Chandigarh-160012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 12865534

Rights and PermissionsRights and Permissions

Subependymomas are highly differentiated slow growing gliomas. They are one of the few gliomas which are biologically benign. They are extremely rare in children. However, after going through the histopathology records of our department of fourteen years (1983-1997) we found that five (20%) cases of subependymomas have been diagnosed in children out of a total of twenty-six subependymomas. Two of our cases showed the presence of osseous metaplasia, a hitherto undescribed finding.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow